Inconsistent standard of care for tuberculosis screening and preventive therapy before initiating systemic psoriasis treatment
LTBI screening and preventive TB therapy for MTX lack standardization. While screening is common for IL-17/IL-23/IL-12/23p40 inhibitors, a significant proportion of LTBI patients receive these treatments without preventive TB therapy.
Authors
- Brit Haecker
- Ruben Heuer (ORCID: https://orcid.org/0000-0002-0207-7373)
- Alexander Nast (ORCID: https://orcid.org/0000-0003-3504-2203)
- Christoph Zeyen (ORCID: https://orcid.org/0000-0002-3355-8663)
- Tom Schaberg
Institutions
- Humboldt-Universität zu Berlin (DE)
- German Central Institute for Social Issues (DE)
- Freie Universität Berlin (DE)
- Charité - Universitätsmedizin Berlin (DE)
Publication Details
- Journal
- JDDG Journal der Deutschen Dermatologischen Gesellschaft
- Published
- 2025-11-28
- DOI
- https://doi.org/10.1111/ddg.15948
- Primary Topic
- Psoriasis: Treatment and Pathogenesis
- Type
- article
- Field-Weighted Citation Impact
- 0.00